GlaxoSmithKline faces fresh drug bribery claims in Syria
14th August 2014
Pharmaceutical firm investigating new claims of bribing doctors made in anonymous email sent to its top managers last week.
GlaxoSmithKline faces new allegations that it bribed Syrian doctors and officials to boost sales of its medicines, following recent accusations of corruption in its non-prescription business in the country.
Read more at source article www.theguardian.com